Zhejiang Supor Pharmaceuticals

Zhejiang Supor Pharmaceuticals is a comprehensive pharmaceutical company based in China, specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. A subsidiary of the Supor Group, the company has established a strong presence in the global market, particularly in the production of macrolide antibiotics such as clarithromycin and azithromycin. Their facilities are compliant with international standards, including US FDA and EU GMP certifications, enabling them to serve as a key supplier and CDMO partner for global pharmaceutical firms. The company's portfolio spans multiple therapeutic areas, including anti-infectives, cardiovascular health, and central nervous system disorders. Supor Pharmaceuticals operates both as a generic manufacturer and a Contract Development and Manufacturing Organization (CDMO), supporting global partners with chemical synthesis and formulation expertise.